Arvinas
Manufacturing · Connecticut, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
395 Winchester Ave, New Haven, Connectic...Phone Number
(203) 535-1456Website
www.arvinas.comRevenue
$316.7 MillionStock Symbol
ARVNIndustry
About Arvinas
Arvinas is a biotechnology company focused on developing innovative medicines through targeted protein degradation. The company uses its proprietary PROTAC platform to design therapies that harness the body’s natural protein disposal system to selectively degrade disease-causing proteins. Its research and development programs focus particularly on oncology and neurological disorders, with additional applications across serious and difficult-to-treat diseases. Arvinas combines drug discovery, clinical development, scientific research, and strategic partnerships to advance novel therapies from early research toward patient care. The company is headquartered in New Haven, Connecticut, and works to create new treatment options for patients with significant unmet medical needs.Explore more
Arvinas Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Arvinas
Compare insights from companies similar to Arvinas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$35M
51-200
Public
$425M
2015
Kendra AdamsChief Financial Officer & Head Corporate Affairs & Principal Accounting Officer
Arvinas Tech Stack
A closer look at the technologies used by Arvinas
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arvinas
Sign Up For FreeTo access detailed company insights
Arvinas is a biotechnology company focused on developing innovative medicines through targeted protein degradation. The company uses its proprietary PROTAC platform to design therapies that harness the body’s natural protein disposal system to selectively degrade disease-causing proteins. Its research and development programs focus particularly on... Read More
